ROCKET PHARMACEUTICALS, INC. - COM (RCKT)

Historical Portfolio Holders from Q1 2018 to Q1 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Equity / COM
Shares, excl. options Q1 2024
91 M
Holdings value Q1 2024
$2.45 B
Value change Q1 2024
+$111 M
Grand Portfolio weight change Q1 2024
+0%
Number of holders
175
Number of buys Q1 2024
83
Number of sells Q1 2024
-85
Average buys Q1 2024 %
+0.001%
Average sells Q1 2024 %
-0.001%
CUSIP
77313F106
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q1 91 M $2.45 B +$111 M $26.94 180
2023 Q4 88.3 M $2.65 B +$5.21 M $29.97 192
2023 Q3 88.4 M $1.81 B +$246 M $20.49 173
2023 Q2 76 M $1.51 B -$36.1 M $19.87 157
2023 Q1 78 M $1.34 B +$44.2 M $17.13 156
2022 Q4 74.7 M $1.46 B +$146 M $19.57 162
2022 Q3 67.8 M $1.08 B +$65.7 M $15.96 153
2022 Q2 63.5 M $873 M +$4.03 M $13.76 136
2022 Q1 62.4 M $990 M +$10.1 M $15.86 136
2021 Q4 63 M $1.38 B +$9.18 M $21.83 135
2021 Q3 60.5 M $1.81 B -$26 M $29.89 138
2021 Q2 60.6 M $2.68 B -$54.4 M $44.29 144
2021 Q1 61.9 M $2.75 B -$19.1 M $44.37 168
2020 Q4 61.9 M $3.39 B +$435 M $54.84 167
2020 Q3 55.1 M $1.26 B +$22.9 M $22.86 119
2020 Q2 53.2 M $1.11 B +$14.4 M $20.93 112
2020 Q1 52 M $725 M +$12.4 M $13.95 98
2019 Q4 51.1 M $1.16 B +$87.9 M $22.76 116
2019 Q3 43.3 M $504 M -$33.1 M $11.65 88
2019 Q2 47 M $705 M +$95.7 M $15.00 92
2019 Q1 39.9 M $699 M +$16.5 M $17.54 79
2018 Q4 38.6 M $570 M +$71.2 M $14.82 81
2018 Q3 33.8 M $832 M +$69.9 M $24.62 79
2018 Q2 31.1 M $605 M +$63.9 M $19.63 74
2018 Q1 28 M $502 M +$502 M $18.75 55